BAX and neoplasm: Tumor cells can acquire resistance to apoptosis by downregulation or mutation of proapoptotic proteins such as BCL2 associated X (BAX) or by the expression of anti-apoptotic proteins like B-cell lymphoma 2 (BCL2).